Company Filing History:
Years Active: 2016
Title: Marco A. Cardone: Innovator in Cytokine Signaling Inhibition
Introduction
Marco A. Cardone is a prominent inventor based in Frederick, MD (US). He has made significant contributions to the field of biotechnology, particularly in the area of cytokine signaling. His innovative work has led to the development of a unique peptide-based inhibitor that has potential therapeutic applications.
Latest Patents
Marco A. Cardone holds a patent for a "Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling." This patent describes a peptide or peptidomimetic that comprises an amino acid sequence based on conserved regions of IL10 or IFN-gamma receptor sequences. The related compounds and compositions, as well as methods for their use, aim to inhibit cytokine signaling, which is crucial in various immune responses.
Career Highlights
Marco A. Cardone is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this esteemed organization highlights his commitment to advancing health-related innovations.
Collaborations
Throughout his career, Marco has collaborated with notable colleagues, including Nadya Tarasova and Giorgio Trinchieri. These partnerships have further enriched his research and development efforts in the field of cytokine signaling.
Conclusion
Marco A. Cardone's contributions to biotechnology, particularly through his patent on cytokine signaling inhibition, showcase his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical research and therapeutic development.